1. Current Practice of Podiatrists in Testing for Diabetic Polyneuropathy and Implementing Foot Care (PROTECT Study Survey 2).
- Author
-
Ziegler D, Burow S, Landgraf R, Lobmann R, Reiners K, Rett K, and Schnell O
- Subjects
- Humans, Cross-Sectional Studies, Germany, Male, Practice Patterns, Physicians' statistics & numerical data, Female, Surveys and Questionnaires, Middle Aged, Adult, Diabetic Neuropathies diagnosis, Diabetic Neuropathies therapy, Podiatry statistics & numerical data, Diabetic Foot diagnosis, Diabetic Foot therapy
- Abstract
Aims: Podiatrists constitute a key member of a multidisciplinary foot care team, but their services remain underutilized. We sought to gain insights into the daily practice of podiatrists focusing on screening for and monitoring of diabetic sensorimotor polyneuropathy (DSPN) as well as foot management., Methods: This cross-sectional survey included 125 podiatrists from 12 federal states across Germany who responded to an online questionnaire., Results: The majority of patients treated in podiatry practices were referred by general practitioners and diabetologists. Screening for or follow-up of DSPN was performed by 36% of the respondents at least once a year, by 28% only at initial examination, by 21% only at suspicion, and by 10% basically at each treatment visit. Instruments to assess vibration, touch/pressure, and temperature sensation were used by 81% to 94% of the podiatrists. Previously undiagnosed DSPN and foot ulcers were detected frequently/very frequently (≥6 cases/mo) by 24.0 and 18.4% of the podiatrists, respectively. Almost all podiatrists advised daily self-monitoring of feet and appropriate foot care and >50% gave advice on medical treatment., Conclusions: Podiatrists play an important role in the detection, monitoring, and management of both DSPN and diabetic foot ulcers, suggesting that the utilization of their services should be fostered., Competing Interests: Disclosure D.Z., R.L., Kh.R, K.R., and O.S. are advisory board members of the National Education Initiative (NAI) and received honoraria for speaking activities from Wörwag Pharma. D.Z. received research grants from Wörwag Pharma. R.La. is also an advisory board member of the NAI and received a grant for prevention activities for the German Diabetes Foundation., (Copyright © 2024 AACE. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF